Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Subscribe To Our Newsletter & Stay Updated
